Zymeworks Inc. (Nasdaq:ZYME)
Health Care/Life Sciences • Biotechnology
CIK 1937653
Company
Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Its product includes Zanidatamab, which is a novel bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2). Zanidatamab's unique binding properties result in multiple mechanisms of action that may enable it to address unmet need in patient populations with HER2-expressing cancers. The company was founded on September 8, 2003 and is headquartered in Middletown, DE.
Address
108 Patriot Drive
Suite A
Middletown, Delaware 19709
108 Patriot Drive
Suite A
Middletown, Delaware 19709
Employees
294
294
Stock Info
Close
$11.98
$11.98
Day Range
11.85 - 12.55
11.85 - 12.55
52 Week Range
6.02 - 13.14
6.02 - 13.14
Average volume
505.65K
505.65K
Short Interest
3.26M (02/15/24)
3.26M (02/15/24)
% of Float Shorted
4.98%
4.98%
Market Cap
$883.87M
$883.87M
Revenue
$412.48M
$412.48M
Net Income
$124.34M
$124.34M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
|
Chairman, President & Chief Executive Officer Kenneth Harry Galbraith |
|
Director Alessandra Cesano MD, PhD |
|
Director Nancy E Davidson MD |
|
Director Scott Benjamin Platshon |
|
Independent Director Carlos E Campoy MBA |
|
Independent Director Troy M Cox MBA |
|
Lead Independent Director Susan Mahony PhD, MBA |
|
Independent Director Kelvin M Neu MD, PhD |
|
Independent Director Hollings Chase Renton III, MBA |
|
Independent Director Derek J Miller MBA |
SEC filings
| Date | Form | Event |
|---|---|---|
| 12 Dec, 2024 | 4 | |
| 12 Dec, 2024 | 4 | |
| 12 Dec, 2024 | 4 | |
| 12 Dec, 2024 | 4 | |
| 12 Dec, 2024 | 4 | |
| 12 Dec, 2024 | 4 | |
| 12 Dec, 2024 | 4 | |
| 12 Dec, 2024 | 4 | |
| 11 Dec, 2024 | 8-K | |
| 21 Nov, 2024 | 8-K | |
| 14 Nov, 2024 | SC 13G/A | |
| 14 Nov, 2024 | SC 13G/A | |
| 13 Nov, 2024 | SC 13G | |
| 31 Oct, 2024 | 10-Q | |
| 31 Oct, 2024 | 8-K | |
| 29 Oct, 2024 | DEF 14A | |
| 29 Oct, 2024 | DEFA14A | |
| 29 Oct, 2024 | ARS | |
| 18 Oct, 2024 | 8-K | |
| 3 Sep, 2024 | 4 | |
| 3 Sep, 2024 | 3 | |
| 3 Sep, 2024 | 8-K | |
| 2 Aug, 2024 | 424B5 | |
| 2 Aug, 2024 | 8-K | |
| 1 Aug, 2024 | 8-K | |
| 1 Aug, 2024 | 8-K | |
| 1 Aug, 2024 | 10-Q | |
| 25 Jul, 2024 | 8-K | |
| 11 Jun, 2024 | 144 | |
| 10 Jun, 2024 | 8-K | |
| 3 May, 2024 | 8-K | |
| 3 May, 2024 | 424B5 | |
| 3 May, 2024 | 424B5 | |
| 2 May, 2024 | S-3ASR | |
| 2 May, 2024 | 10-Q | |
| 2 May, 2024 | 8-K | |
| 4 Apr, 2024 | 8-K | |
| 2 Apr, 2024 | 3 | |
| 2 Apr, 2024 | 4 | |
| 1 Apr, 2024 | 8-K | CEO Change |
| 28 Mar, 2024 | 8-K | |
| 7 Mar, 2024 | RW | |
| 7 Mar, 2024 | S-8 | |
| 7 Mar, 2024 | S-3ASR | |
| 6 Mar, 2024 | 8-K | |
| 6 Mar, 2024 | 10-K | |
| 6 Mar, 2024 | S-3 | |
| 4 Mar, 2024 | 3 | |
| 22 Feb, 2024 | SC 13D | |
| 22 Feb, 2024 | 8-K | |
| 14 Feb, 2024 | SC 13G/A | |
| 14 Feb, 2024 | SC 13G/A | |
| 14 Feb, 2024 | SC 13G/A | |
| 14 Feb, 2024 | SC 13G/A | |
| 9 Feb, 2024 | SC 13G/A | |
| 9 Feb, 2024 | 3 | |
| 9 Feb, 2024 | 4 | |
| 8 Feb, 2024 | 8-K | |
| 29 Jan, 2024 | SC 13G | |
| 8 Jan, 2024 | 4 | |
| 8 Jan, 2024 | 4 | |
| 8 Jan, 2024 | 4 | |
| 8 Jan, 2024 | 4 | |
| 5 Jan, 2024 | 144 | |
| 5 Jan, 2024 | 8-K | |
| 5 Jan, 2024 | 3 | |
| 5 Jan, 2024 | 144 | |
| 5 Jan, 2024 | 144 | |
| 4 Jan, 2024 | 8-K | |
| 3 Jan, 2024 | D | |
| 28 Dec, 2023 | 4 | |
| 26 Dec, 2023 | 8-K | |
| 11 Dec, 2023 | 4 | |
| 8 Dec, 2023 | 4 | |
| 8 Dec, 2023 | 3 | |
| 8 Dec, 2023 | 4 | |
| 8 Dec, 2023 | 4 | |
| 8 Dec, 2023 | 4 | |
| 8 Dec, 2023 | 4 | |
| 8 Dec, 2023 | 4 | |
| 8 Dec, 2023 | 8-K | |
| 8 Dec, 2023 | 4 | |
| 8 Dec, 2023 | 4 | |
| 7 Nov, 2023 | 8-K | |
| 7 Nov, 2023 | 10-Q | |
| 2 Nov, 2023 | 8-K | |
| 26 Oct, 2023 | DEFA14A | |
| 26 Oct, 2023 | DEF 14A | |
| 26 Oct, 2023 | ARS | |
| 16 Oct, 2023 | 8-K | |
| 21 Sep, 2023 | 8-K | |
| 10 Aug, 2023 | 8-K | |
| 10 Aug, 2023 | 10-Q | |
| 30 Jun, 2023 | 3 | |
| 30 Jun, 2023 | 4 | |
| 29 Jun, 2023 | 8-K | |
| 21 Jun, 2023 | SC 13G/A | |
| 21 Jun, 2023 | 4 | |
| 12 Jun, 2023 | 8-K | |
| 12 Jun, 2023 | 8-A12B/A | |
| 5 Jun, 2023 | 8-K | |
| 18 May, 2023 | 8-K | CEO Change |
| 16 May, 2023 | 8-K | |
| 8 May, 2023 | 424B5 | |
| 8 May, 2023 | 424B5 | |
| 8 May, 2023 | 10-Q | |
| 8 May, 2023 | 8-K | |
| 28 Apr, 2023 | EFFECT | |
| 28 Apr, 2023 | 10-K/A | |
| 26 Apr, 2023 | 8-K | |
| 18 Apr, 2023 | 8-K | |
| 10 Apr, 2023 | 4 | |
| 10 Apr, 2023 | 8-K | |
| 10 Apr, 2023 | 3 | |
| 30 Mar, 2023 | 4 | |
| 17 Mar, 2023 | 8-K | |
| 15 Mar, 2023 | 8-K | |
| 14 Mar, 2023 | 4 | |
| 7 Mar, 2023 | 10-K | |
| 7 Mar, 2023 | S-8 | |
| 7 Mar, 2023 | POSASR | |
| 7 Mar, 2023 | 8-K | |
| 7 Mar, 2023 | POS AM | |
| 14 Feb, 2023 | SC 13G/A | |
| 14 Feb, 2023 | SC 13G/A | |
| 14 Feb, 2023 | SC 13G/A | |
| 14 Feb, 2023 | SC 13G/A | |
| 10 Feb, 2023 | SC 13G/A | |
| 10 Feb, 2023 | SC 13G | |
| 2 Feb, 2023 | SC 13G/A | |
| 23 Jan, 2023 | 4 | |
| 19 Jan, 2023 | 8-K | |
| 18 Jan, 2023 | 4 | |
| 12 Jan, 2023 | 4 | |
| 6 Jan, 2023 | 4 | |
| 6 Jan, 2023 | 4 | |
| 6 Jan, 2023 | 4 | |
| 6 Jan, 2023 | 4 | |
| 4 Jan, 2023 | 8-K | |
| 3 Jan, 2023 | SC 13G | |
| 30 Dec, 2022 | 8-K | |
| 28 Dec, 2022 | SC 13D/A | |
| 28 Dec, 2022 | SC 13D/A | |
| 23 Dec, 2022 | 4/A | |
| 23 Dec, 2022 | 4/A | |
| 23 Dec, 2022 | 4 | |
| 23 Dec, 2022 | 4 | |
| 23 Dec, 2022 | 4 | |
| 23 Dec, 2022 | 4 | |
| 23 Dec, 2022 | 4 | |
| 23 Dec, 2022 | 4 | |
| 23 Dec, 2022 | 4 | |
| 23 Dec, 2022 | 4 | |
| 21 Dec, 2022 | 8-K | |
| 19 Dec, 2022 | 8-K | |
| 19 Dec, 2022 | 8-K | |
| 15 Dec, 2022 | CERT | |
| 15 Dec, 2022 | 8-A12B | |
| 15 Dec, 2022 | 25 | |
| 14 Dec, 2022 | 4 | |
| 9 Dec, 2022 | 8-K | |
| 8 Dec, 2022 | DEFA14A | |
| 5 Dec, 2022 | 8-K | |
| 29 Nov, 2022 | 8-K | |
| 18 Nov, 2022 | 8-K | |
| 14 Nov, 2022 | 4 | |
| 9 Nov, 2022 | 8-K | |
| 9 Nov, 2022 | 424B5 | |
| 8 Nov, 2022 | 8-K | |
| 8 Nov, 2022 | 10-Q | |
| 1 Nov, 2022 | SC 13G/A | |
| 1 Nov, 2022 | 3 | |
| 28 Oct, 2022 | SC 13G | |
| 28 Oct, 2022 | 8-K | |
| 21 Oct, 2022 | 8-K | |
| 21 Oct, 2022 | 424B5 | |
| 19 Oct, 2022 | 8-K | |
| 18 Oct, 2022 | 4/A | |
| 17 Oct, 2022 | SC 13G | |
| 17 Oct, 2022 | 4 | |
| 17 Oct, 2022 | 3 | |
| 17 Oct, 2022 | 3 | |
| 13 Oct, 2022 | S-8 POS | |
| 13 Oct, 2022 | S-8 POS | |
| 13 Oct, 2022 | S-8 POS | |
| 13 Oct, 2022 | S-8 POS | |
| 13 Oct, 2022 | POSASR | |
| 13 Oct, 2022 | 8-K12B | |
| 13 Oct, 2022 | 8-K | |
| 13 Oct, 2022 | 424B5 | |
| 7 Oct, 2022 | S-4MEF | |
| 2 Sep, 2022 | EFFECT | |
| 2 Sep, 2022 | 424B3 | |
| 30 Aug, 2022 | CORRESP | |
| 19 Aug, 2022 | CORRESP | |
| 19 Aug, 2022 | S-4/A | |
| 8 Aug, 2022 | UPLOAD | |
| 15 Jul, 2022 | S-4 | |
| 15 Jul, 2022 | 425 | |
| 15 Jul, 2022 | 425 | |
| 15 Jul, 2022 | 425 | |
| 15 Jul, 2022 | 425 | |
| 15 Jul, 2022 | 425 |
Last update:2024-03-06 12:28:17.067579
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.